Study of Yupingfeng Powder Treating Allergic Rhinitis (AR)

Clinical trial NCT06608017 · RECRUITING

Trial details

NCT number: NCT06608017
Sponsor: Chinese University of Hong Kong
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Allergic Rhinitis

Start date: 2025-03-27
Primary completion: 2026-12-31
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.